Shimiao (Felix） Yu

Shimiao (Felix) Yu has a wealth of experience in the biotechnology industry. Shimiao (Felix） began their career in 2013 as a Sales Account Manager for GenScript, Inc., where they were responsible for quotation and order follow-up in the EU & African territory, driving sales with an annual target of $4million, increasing key account base, contract management, and working closely with the marketing team to develop promotional plans. In 2015, they moved to Pangogene Bioscience Ltd. as an Associate Director of Sales. In 2018, they joined BGI Genomics as a Senior Project Coordinator. Currently, they are the Director of Business Development at HitGen Inc., where they are responsible for the company's DNA Encoded Library (DEL) drug discovery technology.

Shimiao (Felix) Yu completed an MBA from Macquarie Graduate School of Management (MGSM) in 2017, with a focus on business administration. Prior to that, they obtained a Master's Degree from The Australian National University in 2013, with a focus on biotechnology.